Logo

Plasso Raises $2.8 Million in Private Financing

Jan 19, 2005

NEW YORK, Jan. 19 (GenomeWeb News) - Plasso Technology has raised $2.8 million in a second round of financing from an undisclosed, Boston-based institutional investor.

 

The Sheffield, UK-based firm is developing a surface modficiation technology for application to consumables such as microarrays, lab-on-a-chip, sensors, and microtitre plates used in life science research and diagnostics. The firm was spun out of the University of Sheffield in 2003, and its previous investors include the White Rose Technology Seedcorn Fund, Sheffield University Enterprises, and East Hill Management.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.